FDA Okays Beleodaq to Treat Non-Hodgkin Lymphoma

July 4, 2014 6:26 AM

15 0

The U.S. Food and Drug Administration, to treat a rare and aggressive form of non-Hodgkin Lymphoma, gave a nod to Beleodaq.

Peripheral T-cell lymphoma (PTCL) is a rare and fast growing type of non-Hodgkin lymphoma (NHL). PTCL consists of a varied group of rare disease where the lymph nodes become cancerous. The National Cancer Institute estimated that in 2014, nearly 70,800 Americans will be diagnosed with NHL and nearl...

Read more

To category page

Loading...